摘要
结直肠癌(CRC)的早期诊断具有重要临床意义。外周血SEPT9基因甲基化在大量研究中被证实是CRC的特异性生物学标记物,敏感性和特异性均较高,较之目前常用的粪便隐血试验、血清肿瘤标记物和结肠镜筛查具有一定优势,但在筛查腺瘤、息肉等癌前病变中的应用价值有限,用于评估CRC术后复发和放化疗效果的潜力则尚需进一步临床验证。本文就外周血SEPT9基因甲基化检测在CRC筛查中的应用进展作一综述。
The early detection and diagnosis of colorectal cancer（ CRC） is of great clinical importance. Peripheral blood methylated SEPT9 gene was found to be a sensitive and specific biomarker for CRC and was superior to other commonly used screening methods such as fecal occult blood test,serum tumor markers and colonoscopy in a variety of studies. But it is of limited value in screening of adenomas,polyps and other precursors of CRC,and its capacities for assessment of cancer recurrence and therapeutic effects of radiotherapy and chemotherapy need further clinical validation.This article reviewed the progress in application of peripheral blood methylated SEPT9 gene assay for CRC screening.
出处
《胃肠病学》
2017年第10期619-622,共4页
Chinese Journal of Gastroenterology
